Entegrion’s products seek to fill unmet market needs.
- Our plasma and platelet technologies bridge a gap in current blood banking technology that dates back more than half a century.
- Our PCM will provide data faster to doctors and directly to first responders, accelerating life-saving therapies.
Building from these unique technologies provides us with a significant platform for expansion.
- Our Resusix™ and Stasix® technologies are the foundation of our hemostatic patch.
- And our Stasix® particles can be loaded with imaging and highly cytotoxic materials for targeted delivery to areas of vascular distress.
Entegrion actively seeks partnerships for development and commercialization of our unique product line.
If interested in learning more, click here.
|our products have tremendous potential for serving unmet medical needs in global health settings. —Joseph DaCorta,
Chief Technology Officer